Antibiotics, Antitubercular
-
Subject Areas on Research
- A pilot evaluation of alfentanil-induced miosis as a noninvasive probe for hepatic cytochrome P450 3A4 (CYP3A4) activity in humans.
- Antimicrobial activity of prosthetic heart valve sewing cuffs coated with minocycline and rifampin.
- Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.
- Improved tuberculosis outcomes with daily vs. intermittent rifabutin in HIV-TB coinfected patients in India.
- Influence of hepatic and intestinal cytochrome P4503A activity on the acute disposition and effects of oral transmucosal fentanyl citrate.
- Interception of host angiogenic signalling limits mycobacterial growth.
- Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
- Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models.
- Optimising pyrazinamide for the treatment of tuberculosis.
- Rifampin use and safety in hospitalized infants.
- STRUCTURE OF STREPTOLYDIGIN.
- Sacral tuberculosis: a case report and review of the literature.
- Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis.
- Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
- Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.
- The complexities of Xpert® MTB/RIF interpretation.
- The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse.
- Treating latent tuberculosis with rifampin: is it the cheaper option?